Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Industrial Research Assistance Program – Contributions to Firms

Innovakine Therapeutics Inc.

$40,000.00

Cellular Therapy Market Assessment

FY 2020-21 · 2020-06-08

Summary
Innovakine has developed an innovative platform technology with the potential to enhance the efficacy and safety of engineered cell therapies across multiple disease indications, including cancer, infectious disease, autoimmunity, transplantation and regenerative medicine. The current project will constitute a competitive landscape analysis that will enable Innovakine to prioritize the most promising medical and commercial applications of its technology.
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
776996274
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

Amendments

Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.

AmendmentDateFiscal YearTotal
02020-06-082020-21$20,000.00
12020-06-082020-21$40,000.00

As published

Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 109 days. The total amended value is 20,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 109 jours. La valeur totale des modifications est de 20 000 dollars.
Agreement End Date
2020-12-31
Agreement Number
952346
Agreement Start Date
2020-06-08
Agreement Title
Cellular Therapy Market Assessment
Agreement Title (French)
Évaluation du marché de la thérapie cellulaire
Agreement Type
Contribution
Agreement Value
$40,000.00
Amendment Date
2020-09-03
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Innovakine has developed an innovative platform technology with the potential to enhance the efficacy and safety of engineered cell therapies across multiple disease indications, including cancer, infectious disease, autoimmunity, transplantation and regenerative medicine. The current project will constitute a competitive landscape analysis that will enable Innovakine to prioritize the most promising medical and commercial applications of its technology.
Description (French)
Innovakine a mis au point une plateforme technologique novatrice susceptible d'améliorer l'efficacité et la sécurité des thérapies cellulaires artificielles dans de multiples indications de maladies, notamment le cancer, les maladies infectieuses, l'auto-immunité, la transplantation et la médecine régénérative. Le projet actuel constituera une analyse du contexte concurrentiel qui permettra à Innovakine de donner la priorité aux applications médicales et commerciales les plus prometteuses de sa technologie.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Centre
Federal Riding (French)
Vancouver-Centre
Federal Riding Number
59034
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
776996274
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Innovakine Therapeutics Inc.
Recipient Postal Code
V7X 1L3
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q1-952346